Abiopharma

🔍 Roberts David B (Executive)

Company: Anteris Technologies Global Corp. (AVR)

Report Date: 2026-06-07

Detailed Transactions and Holdings:

• Acquired 17,580 shares of Common Stock (Direct)
  Date: 2026-06-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 17,580.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 17,580 shares of Restricted Stock Units (Derivative)
  Date: 2026-06-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 35,162.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2

Footnotes:

• F1: Each restricted stock unit ("RSU") converts into a share of common stock on a one-for-one basis.
• F2: On December 3, 2025, the reporting person was granted 52,742 RSUs that generally vest in approximately equal installments on June 7, 2026, June 7, 2027 and June 7, 2028, subject to the Reporting Person's continued service through each vesting date.